Keros is a clinical-stage company dedicated to the development and commercialization of innovative therapeutics aimed at treating a diverse range of disorders associated with the TGF-ß protein family.
Arkin Entry Stage
Late
Status
IPO
Location
Boston, MA
Let’s get in touch!
